Home/Accure Therapeutics/Pablo Villoslada
PV

Pablo Villoslada

Chief Scientific Officer

Accure Therapeutics

Accure Therapeutics Pipeline

DrugIndicationPhase
ACT-03Post-Traumatic EpilepsyPre-clinical
Unnamed ProgramParkinson's DiseasePre-clinical